Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Cholest-4-en-3-one, oxime

EU orphan designation number: EU/3/05/264   
Active ingredient: Cholest-4-en-3-one, oxime
Indication: Treatment of 5q spinal muscular atrophies
Sponsor: Trophos SA
Parc scientifique de Lumigny, Case 931, Luminy Biotech Entreprise, F-13288 Marseille CEDEX 09, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2005 Centralised Orphan - Designation EMEA/OD/081/04 (2005)816 of 10/03/2005